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InteractionThe SH2-containing inositol 5′-phosphatase, SHIP1, negatively regulates signal transduction from the B cell
antigen receptor (BCR). The mode of coupling between SHIP1 and the BCR has not been elucidated so far.
In comparison to wild-type cells, B cells expressing a mutant IgD- or IgM-BCR containing a C-terminally trun-
cated Ig-α respond to pervanadate stimulation with markedly reduced tyrosine phosphorylation of SHIP1
and augmented activation of protein kinase B. This indicates that SHIP1 is capable of interacting with the
C-terminus of Ig-α. Employing a system of ﬂuorescence resonance energy transfer in S2 cells, we can clearly
demonstrate interaction between the SH2-domain of SHIP1 and Ig-α. Furthermore, a ﬂuorescently labeled
SH2-domain of SHIP1 translocates to the plasma membrane in an Ig-α-dependent manner. Interestingly,
whereas the SHIP1 SH2-domain can be pulled-down with phospho-peptides corresponding to the immu-
noreceptor tyrosine-based activation motif (ITAM) of Ig-α from detergent lysates, no interaction between
full-length SHIP1 and the phosphorylated Ig-α ITAM can be observed. Further studies show that the SH2-
domain of SHIP1 can bind to the C-terminus of the SHIP1 molecule, most probably by inter- as well as
intra-molecular means, and that this interaction regulates the association between different forms of
SHIP1 and Ig-α.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
The hemopoietic-speciﬁc SH2-domain-containing inositol 5′-
phosphatase 1 (SHIP1) is known as an important negative regulator
of the phosphatidylinositol 3-kinase (PI3K) pathway [1]. It comprises
an N-terminal SH2-domain, a central catalytic domain, and a proline-
rich C-terminus containing two NPXY sequences which, after phos-
phorylation on tyrosines, can interact with PTB-domain-containing
adaptor proteins, like Shc or Dok1 [1]. SHIP1 is critically involved in
the downregulation of activation signals from the BCR after coligation
of the BCR with the inhibitory receptor, FcγRIIB (CD32), through IgG-
antigen immune complexes [2,3]. In such a scenario, the PTK Lyn
phosphorylates the tyrosine residue within the FcγRIIB ITIM, thus
creating a docking site for the SH2-domain of SHIP1 [4]. By this wayry andMolecular Immunology,
Clinic, RWTHAachenUniversity,
1 80 88830; fax: +49 241 80
rk.
l rights reserved.SHIP1 is recruited to the plasma membrane and hydrolyzes its sub-
strate, phosphatidylinositol-3,4,5-trisphosphate (PIP3), thereby inhi-
biting various BCR-mediated, PIP3-dependent responses, e.g. calcium
mobilization [3]. Moreover, SHIP1 bound to the FcγRIIB can fulﬁll a
phosphatase-independent adaptor role by interacting with Dok1
and RasGAP, thus contributing to the suppression of MAPK activation
[5]. However, SHIP1 not only acts downstream from the inhibitory
FcγRIIB, but has also been demonstrated to be tyrosine-
phosphorylated in response to antigen stimulation and has an
attenuating role for the signal emitted from the BCR itself [6–9].
Furthermore, we could establish SHIP1 as a crucial gatekeeper of
mast cell degranulation by acting downstream of the activating
immunoreceptor FcεR1 and restricting PI3K-mediated signals
[10,11]. In the case of the FcεR1, it is thought that SHIP1 binds to
the phosphorylated ITAM of the β-subunit of the FcεR1 by means of
its SH2-domain [12]. However, it is still not known how SHIP1 func-
tion is coupled to the BCR.
Although there is only one gene for SHIP1 multiple forms of this
signaling protein can be found in different cells. In cell lineages of
the bone marrow and the blood, expression of SHIP1 forms changes
according to both the developmental stage and differentiated lineage
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and 135 kDa in length with alterations in the C-terminal tail of
SHIP1, which is thought to be important for mediating protein–
protein interactions, have been identiﬁed [14,15]. Complicating
the picture, SHIP1 protein has been shown to be C-terminally cleaved
yielding additional forms (110, 125, and 135 kDa in length) [16]. Fur-
thermore, a SHIP1 isoform, s-SHIP, particularly expressed in embryon-
ic and hemopoietic stem cells has been described lacking the SH2-
domain and being unable, in contrast to full-length SHIP1, to interact
with the adaptor protein Shc [17]. Despite this increasing knowledge
about different forms of SHIP1 the functional implications of these
ﬁndings are still lacking.
Signals generated by the BCR are required for the activation, pro-
liferation, and differentiation of B cells [18]. The BCR comprises the
membrane-bound immunoglobulin (mIg), which carries the two an-
tigen binding sites and the disulﬁde-bridged Ig-α/Ig-β heterodimer,
which is non-covalently bound to mIg and mediates the signal trans-
duction of the BCR [19]. Due to the predominant activating nature of
the BCR and since there is a so-called functional dichotomy between
ITAM and ITIM sequences (as mentioned above), it was very intrigu-
ing when two groups studying mutant mice which carried a C-
terminal truncation of Ig-α published a negative signaling role for
Ig-α in immature B cells [20,21]. Immature B cells from these Ig-α
mutant mice responded to BCR engagement with an exaggerated
and prolonged calcium response and induction of protein tyrosine
phosphorylation. These data indicated that in particularly Ig-α was
involved in coupling the BCR to negative signaling elements.
In this report we present data demonstrating that the SH2-domain
of SHIP1 is capable of binding to the phosphorylated ITAM of the Ig-α
subunit of the BCR. However, the C-terminus of SHIP1 can also interact
with the SH2-domain of SHIP1, thus enabling intra-/inter-molecular
SHIP1 interactions and most likely competition with the Ig-α ITAM.
C-terminally truncated versions of SHIP1, which have lost the ability
for intra-molecular SHIP1 interaction, however, bind to Ig-α in an en-
hanced manner. These data indicate that at least part of Ig-α's nega-
tive regulatory potential is realized by the association with the
well-known negative regulator SHIP1.
2. Materials and methods
2.1. Cell culture
The J558L myeloma cells and transfectants were maintained
(37 °C, 5% CO2) in RPMI 1640 medium supplemented with 10% fetal
calf serum (FCS), 2 mM L-glutamine, 50 units/ml penicillin, 50 mg/ml
streptomycin, and 50 μM 2-mercaptoethanol. J558L∂mwt [22] express
an IgDwt-BCR and J558L∂mM6 transfectants express an IgD-BCR
with an intracellularly truncated Ig-α subunit lacking the ITAM
[23]. All mIg molecules of the different J558L cell lines carry the
antigen-binding site of the monoclonal antibody B1-8, which is spe-
ciﬁc for the hapten NP. Schneider S2 cells were grown in Schneider's
Drosophila medium (Life Technologies, Inc., Karlsruhe, Germany) sup-
plemented with 10% FCS at 27 °C without CO2. Cells were passaged
every 2 to 3 days to maintain exponential growth. Bone marrow-
derived mast cells (BMMCs) were differentiated and cultured as de-
scribed [24].
2.2. Reagents
Monoclonal anti-phosphotyrosine antibodies (4G10) were pur-
chased from Biozol (Eching, Germany) and polyclonal anti-Shc anti-
bodies from BD Transduction Laboratories (Heidelberg, Germany).
Polyclonal anti-Syk (N19), monoclonal anti-SHIP1 (P1C1) and poly-
clonal anti-SHIP1 (N1 and M14) antibodies were obtained from
Santa Cruz (Heidelberg, Germany). The monoclonal antibodies
against BAP32 have been described previously [25]. Biotinylated andphosphorylated peptide (biotin-TKPEMFENPLpYGSVSS) correspond-
ing to amino acids 1011–1026 of murine SHIP1 was obtained from
GL Biochem, Shanghai. Dephosphorylation of the phospho-peptide
was achieved using calf intestinal phosphatase from New England
Biolabs (1 μl enzyme in a 30 μl volume, 37 °C, 30 min; NEB Buffer 3).
Efﬁciency of dephosphorylation was tested by spotting peptides on
PVDF membrane and immunoblot analysis (4 G10). Recombinant
GST and GST-SH2(SHIP1) were produced according to Leitges et al.
[26]. To obtain the plasmid pD-HASHIP1, the plasmid HASHIP1cD-
NAmBS (provided by Dr. G. Krystal) was digested with EcoRI/XhoI,
blunted, and cloned into the SmaI-digested Drosophila expression
vector pRmHa-3. The plasmid pD-ΔSH2-SHIP1 was generated from
pD-HASHIP1 by QuickChange mutagenesis/deletion using the follow-
ing primers: sense primer: GCC TGC CAT GGT CCC TGG GCT GGA GGA
GGA GGA TGC TAT TG; antisense primer: CAA TAG CAT CCT CCT CCT
CCA GCC CAG GGA CCA TGG CAG GC. Using QuickChange mutagene-
sis, a Stop codon was introduced into pD-HASHIP1 instead of the trip-
let coding for Y798 yielding pD-HASHIP1 Y798Stop. Primers were the
following: sense: CCC ATT ATC TCT GAC CCC GAA TAA TTA CTG GAC
CAG C; antisense: G CTG GTC CAG TAA TTA TTC GGG GTC AGA GAT
AAT GGG. To obtain the plasmid pD-SH2(SHIP1)-YFPv, the cDNA for
the SH2-domain of SHIP1 (sense primer: CGG AAT TCA TGC CTG
CCA TGG TCC CTG GG; antisense primer: GGG GTA CCG TCC TTG
GCC TCG CTG GG) and the cDNA for YFPv (sense primer: GGG GTA
CCA TGG TGA GCA AGG GCG; antisense primer: CGG GAT CCT TAC
TTG TAC AGC TCG TCC) were ampliﬁed by PCR. The SHIP1-SH2 frag-
ment was cut with EcoRI/KpnI, and the YFPv fragment with KpnI/
BamHI, and were ligated into pRmHa-3, which was opened with
EcoRI/BamHI. Expression vectors coding for Ig-α-ECFP (pD.LFLAG-
mb1-ECFP.II) and Ig-αtl-ECFP (pD.LFLAG-mb1TL-ECFP.II) were
cloned using standard recombinant DNA techniques including PCR.
The Ig-α-ECFP.II fusion contains, from the N terminus, the following
features (ﬂuorophore sequence parts underlined; linker sequences
italic): Ig-α-Linker-ECFP ({…}AQLEKP-SGGGGSGGGG-MVSKGE{…}
DELYK). Ig-α-tl-ECFP.II contains Ig-αtl-Linker-ECFP ({…}GTLLLFR-
SGGGGSGGGG-MVSKGE{…}DELYK). All newly cloned plasmids have
been veriﬁed by DNA sequencing. All other Drosophila expression
plasmids have been described recently [27].
2.3. Activation of B cells, precipitation, and Western blotting
Cells (2×106/ml) were starved for 30 min at 37 °C in RPMI 1640
and stimulated with different concentrations of PV for the indicated
times. The PV solution was prepared according to Baumann et al.
[28]. After stimulation, cells were pelleted for 20 s in a tabletop centri-
fuge and solubilized with 0.5–1.0% NP-40 (Calbiochem, Bad Soden,
Germany) at 4 °C in phosphorylation solubilization buffer (PSB) [29].
Total cell lysates (TCL) corresponding to 3×105 cell equivalents
were directly separated by SDS-PAGE and subjected to Western blot
analysis as described previously [22]. For immunoprecipitation, 5 μg
of the respective antibody was added to the cell lysates and incubated
on a rotator at 4 °C for 4 h followed by a 1 h incubation with 10 μl of
proteinG-sepharose beads. Precipitates were washed three times
with PSB containing one third of the concentration of detergent as
for lysis and analyzed by Western blotting.
2.4. Peptide pulldown
Lysates from untreated or PV-stimulated J558L∂m cells (1.5×107/
point) were prepared as described. Lysates were precleared for 1 h
with 13 μl of streptavidin-agarose-beads (Novagen,Darmstadt, Germany)
and then subjected to an overnight afﬁnity-puriﬁcation with 1 μM of the
respective N-terminally biotinylated peptide plus 13 μl of streptavidin-
agarose-beads. The precipitates were washed twice with PSB containing
0.3%NP-40 andwere analyzed byWestern blotting. Biotinylated peptides
encompass unphosphorylated or doubly-phosphorylated amino acids
Fig. 1. SHIP1 tyrosine phosphorylation is dependent on the Ig-α C-terminus. A.
J558L∂m and J558L∂mM6 cells were left untreated or stimulated with 10 μM PV for
3 min. The cells were lysed and PS were subjected to anti-SHIP1 (P1C1) immunopre-
cipitation. The precipitates were analyzed by anti-Ptyr (upper panel) and anti-SHIP1
(P1C1) Western blotting (lower panel; loading control). The SHIP1 forms are marked
with arrows. B. J558Lμm and J558LμmM6 cells were treated as described in (A).
SHIP1 tyrosine phosphorylation was analyzed accordingly. C. J558L∂m and
J558L∂mM6 cells were left unstimulated (−) or treated with 3 μM PV for the indicated
times. PS were then analyzed for expression of P-PKB (upper panel). The membrane
was reprobed with anti-PKB antibodies (lower panel; loading control). P-PKB and
PKB are indicated by arrows.
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190–209 (P-PepII) of murine Ig-α [30] and unphosphorylated or phos-
phorylated peptides corresponding to the ITIM sequence of the FcγRIIB
C-terminus (ITIM and P-ITIM) [31].
2.5. S2 cell transfections
S2 cell transfections were done as previously described [27]. S2 cells
were transfected using the cationic lipid CellFectin (Life Technologies,
Inc.). The S2 cellswere spread in a 6-well plate (Greiner, Frickenhausen,
Germany) at 1×106 cells per well in 3 ml medium. Supercoiled plas-
mids (0.3 μg of each plasmid was adjusted with the Drosophila expres-
sion vector pRmHa-3 to 3 μg per well) were complexed with lipid
(10 μl CellFectin Reagent) in Schneider's Drosophilamedium. The com-
plex was incubated at room temperature for 15 min, ﬁlled up to 1 ml,
and then added to cells from which normal growth medium had been
removed (cells were washed 1× with medium without FCS). After
18 h, the complex was removed and replaced by Schneider's Drosophila
medium containing FCS and incubated for further 24 h. To induce the
production of proteins, CuSO4 was added to the culture to a ﬁnal con-
centration of 1 mM for 24 h. CuSO4-induced cells were then harvested,
washed once with PBS, and lysed as described above.
2.6. FRET analysis
FRET studies were performed using a ﬂow cytometric approach
previously described [32,33]. Ig-α-ECFP or Ig-α-TL-ECFP where
cotransfected with Ig-β or Ig-β-TL, scδm (coding for a single-chain
mIgD), SH2(SHIP1)-YFPv and Syk in Drosophila S2 cells. After 24 h
of induction with CuSO4, protein expression of these constructs was
stopped by incubating the cells with CuSO4-free medium for 2 h.
Cells were harvested and washed with FACS buffer (PBS containing
3% FCS) before analysis on a BD LSR II cytometer (Becton Dickinson).
Excitation was done with a 405 nm coherent VioFlame laser (Becton
Dickinson) and a 488 nm air-cooled coherent argon-ion Sapphire
Laser (Becton Dickinson) for ECFP or YFPv, respectively. ECFP was
detected using a 470/15 nm bandpass ﬁlter. YFPv and FRET were
detected using a 530/30 nm bandpass ﬁlter, after excitation with the
488 nm and 405 nm laser, respectively. Sequential excitation allowed
for the detection of all three signals (ECFP, YFPv, and FRET) from a
single cell. Compensation was applied so that no FRET signal was de-
tectable in samples transfected with Ig-α-ECFP or SH2(SHIP1)-YFPv
alone. In order to normalize for transfection efﬁciency, 50,000 cells
expressing both ECFP and YFPv were analyzed for FRET signals
using the FACSDiva Software (Becton Dickinson).
2.7. Confocal microscopy studies
For transfection and inspection, 6×105 S2 cells were cultured in
glass bottom wells. Fluorescing fusion proteins were visualized with
a confocal laser scanner (Leica SP2, Leica Microsystems GmbH, Ger-
many) mounted onto an inverted microscope (Leica DM IRE2, Leica
Microsystems GmbH, Germany) using a 63× water immersion lens
(HCX PL APOCS 63.0×1.20 W). Excitation was done with a 488 nm
laser and a 514 nm laser for YFPv samples and EGFP samples, respec-
tively. Emission of YFPv was detected in the range of 525–600 nm and
EGFP in the range of 500–550 nm.
3. Results
3.1. PV-induced tyrosine phosphorylation of SHIP1 is dependent on the
C-terminus of Ig-α
In previous experiments we compared J558Lμm cells expressing a
wild-type IgM-BCR and J558LμmM6 cells expressing an IgM-BCR with
a C-terminally truncated Ig-α with respect to their PTK substratetyrosine phosphorylation after PV treatment. A 145 kDa protein
(pp145) was tyrosine-phosphorylated signiﬁcantly stronger in the
J558Lμm cells compared to J558LμmM6 cells [34]. Comparable re-
sults were obtained analyzing J558Lδm and J558LδmM6 cells
(Suppl. Fig. 1). Due to size and tyrosine phosphorylation, we tested
whether this protein was the SH2-containing inositol 5-phosphatase
SHIP1. J558L∂mwt and J558L∂mM6 cells were left untreated or stimu-
lated with a PV dose (10 μM), which resulted in a comparable general
substrate tyrosine phosphorylation in both cell types. Postnuclear ly-
sates were then subjected to anti-SHIP1 immunopuriﬁcations. The pre-
cipitates were analyzed by anti-Ptyr followed by anti-SHIP1 Western
blotting. Indeed, two SHIP1 forms (p145 and p135) were strongly
tyrosine-phosphorylated in PV-treated wild-type cells, whereas only
weak SHIP1 tyrosine phosphorylation was detectable in J558L∂mM6
cells (Fig. 1A). A comparable difference in SHIP1 tyrosine phosphoryla-
tion was detected between PV-treated J558Lμmwt and J558LμmM6
cells (Fig. 1B). These data suggest that SHIP1 tyrosine phosphorylation
in response to PV stimulation is critically dependent on the presence
of the C-terminus of Ig-α. Since SHIP1 is known to suppress activation
of the PI3K-dependent kinase PKB by hydrolyzing PIP3 [35], we as-
sumed a positive effect of truncated Ig-α on PKB phosphorylation. In-
deed, it was found that the mutant cells responded in an augmented
manner. Activation of PKB in response to PV was faster in the mutant
cells (0.5 min) compared to wild-type cells (3 min) and also stronger
throughout the time-course experiment (Fig. 1C).
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plasma membrane
SHIP1 tyrosine phosphorylation was dependent on the presence of
the ITAM-containing Ig-α C-terminus. Thus, we reasoned that SHIP1
might bind to the phosphorylated Ig-α ITAM, probably via its SH2-
domain, to become phosphorylated by a BCR-proximal PTK. Using
the Scoring Matrix-Assisted Ligand Identiﬁcation (SMALI) web tool,
we analyzed ITAM sequences of murine BCR, TCR, and FcεR1 (a total
of 10 ITAMs in 8 proteins) for potential interaction with SH2-
domain-containing proteins [36]. Interestingly, 4 and 6 ITAM tyro-
sines were predicted to bind to SHIP1 and SHIP2, respectively (data
not shown). Thus, we analyzed the interaction of SHIP1's SH2-
domain with Ig-α in living cells. We used the Drosophila S2 reconsti-
tution system [27] to monitor translocation of a yellow ﬂuorescence
protein (YFPv)-tagged SH2-domain of SHIP1 (SH2(SHIP1)-YFPv) to
the BCR at the plasma membrane of S2 cells. As a control, S2 cells
were co-transfected with a complete BCR or a BCR containing C-
terminally truncated versions of Ig-α and Ig-β (BCRtl) and Syk-GFP.
In the case of a complete BCR, Syk-GFP almost exclusively translo-
cated to the plasma membrane (Fig. 2A), whereas Syk-GFP was dis-
persed throughout the cells when BCRtl was co-expressed (Fig. 2B).
Likewise, the SH2(SHIP1)-YFPv protein was evenly distributed in
cells in the presence of the BCRtl and Syk (Fig. 2D) whereas, itFig. 2. Ig-α-dependent translocation of SH2(SHIP1)-YFPv to the plasma membrane. A.–F. Dr
ization of the ﬂuorescent proteins, GFP-Syk (A, B) and SH2(SHIP1)-YFPv (C–F), was analyzed
BCRtl: sc∂m+Ig-αtl+Ig-βtl; BCR/Ig-βtl: sc∂m+Ig-α+Ig-βtl; BCR/Ig-αtl: sc∂m+Ig-αtl+I
and methods) and the percentage of FRET signal-positive cells per ECFP+YFPv-double posit
obtained in separate experiments.translocated to patches in the plasma membrane when co-
expressed with Syk and the complete BCR (Fig. 2C). Membrane trans-
location of SH2(SHIP1)-YFPv was still observed with a BCR containing
wild-type Ig-α and a C-terminally truncated version of Ig-β (Ig-βtl)
(Fig. 2E). This was however completely lost when wild-type Ig-β
was paired with a C-terminally truncated Ig-α (Ig-αtl) (Fig. 2F).
This was in agreement with the SMALI prediction, since Ig-β was
the only murine immunoreceptor subunit, which was predicted to
bind neither to SHIP1 nor to SHIP2 (data not shown) [36]. In conclu-
sion, our results obtained by these translocation studies indicate that
SHIP1 via its SH2-domain is capable of interacting with the BCR via its
signaling subunit Ig-α. It has to be emphasized that the translocation
of SH2(SHIP1)-YFPv to Ig-α can be identiﬁed in living cells even in
the presence of a well-known potent competitor for Ig-α binding,
the PTK Syk (see Fig. 2A).
3.3. FRET measurements reveal interaction between the SH2-domain of
SHIP1 and Ig-α in living cells
To strengthen the results obtained by translocation studies
(Fig. 2A–F), we sought to use a ﬂow cytometric approach to analyze
ﬂuorescence resonance energy transfer (FRET) [32,33] between
SH2(SHIP1)-YFPv and an Ig-α fused to enhanced cyan ﬂuorescent
protein at the C-terminus (Ig-α-ECFP) in the S2 cell system. As aosophila S2 cells were transfected with plasmids encoding the indicated proteins. Local-
by confocal microscopy as described in Material andmethods. BCR: sc∂m+Ig-α+Ig-β;
g-β. G. S2 cells transfected as indicated were analyzed for FRET (as described inMaterial
ive cells is shown in a bar diagram. Each bar is the mean±SD. Comparable results were
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YFPv (ECFP-YFPv) was expressed. Cells expressing this fusion protein
yielded approximately 95% of FRET signal-positive cells (Fig. 2G). As a
negative control, where no speciﬁc interaction between the
ﬂuorophore-carrying molecules was supposed to occur,
SH2(SHIP1)-YFPv and Syk together with a BCRtl containing Ig-αtl-
ECFP were expressed. For double-positive cells, about 6% of FRET
signal-positive cells (background) were measured (Fig. 2G). When
BCRtl was exchanged against the complete BCR containing Ig-α-
ECFP, 27% of FRET signal-positive cells were observed, verifying the
direct interaction between SH2(SHIP1)-YFPv and Ig-α (Fig. 2G). As
observed in our translocation studies, exchanging Ig-β against Ig-βtl
did not result in a reduction of interaction (Fig. 2G). It has to be
underscored that the FRET signal between SH2(SHIP1)-YFPv and Ig-
α-ECFP can be measured in living cells even in the presence of Syk,
a potent competitor for Ig-α binding (see Fig. 2A).
3.4. Full-length SHIP1 does not bind to a phosphorylated Ig-α ITAM
peptide
In agreement with our translocation and FRET data (Fig. 2), the
SH2(SHIP1)-YFPv fusion protein expressed in S2 cells was pulled-
down from detergent lysates not only by the FcγRIIB P-ITIM peptide,
but also – albeit to a reduced extent – by the Ig-α P-ITAM peptide (P-
PepI) (Fig. 3B). The used peptides are depicted in Fig. 3A. TheFig. 3. In the context of full-length SHIP1 the SH2-domain seems to be unable to inter-
act with P-ITAM. A. Schematic view of the ITIM (a) and ITAM (b) peptides used in this
study. B. PS from S2 cells expressing SH2(SHIP1)-YFPv were subjected to afﬁnity-
puriﬁcation with biotinylated Ig-α peptides (PepI, P-PepI, PepII, P-PepII) or FcγRIIB
peptides (ITIM, P-ITIM). As a control, lysates were incubated only with the precipitat-
ing agent, streptavidin-agarose-beads (con). Subsequently, puriﬁed proteins were an-
alyzed by anti-GFP Western blotting. SH2(SHIP1)-YFPv is marked by an arrow. C.
Proteins from unstimulated (−) or PV-stimulated J558L∂m cells were afﬁnity-
puriﬁed with biotinylated Ig-α peptides (PepI, P-PepI, P-PepII) or FcγRIIB peptides
(ITIM, P-ITIM). As a control, lysates were incubated only with the precipitating agent,
streptavidin-agarose-beads (con). Subsequently, puriﬁed proteins were analyzed by
anti-SHIP1 (P1C1; top panel), anti-Syk (middle panel), and anti-Shc immunoblotting
(bottom panel). The SHIP1 forms are marked with arrows.interaction was speciﬁc for the P-PepI peptide, since neither unpho-
sphorylated ITAM or ITIM peptides (PepI, ITIM) nor the P-PepII pep-
tide comprising the C-terminal ITAM tyrosine plus Y204 (necessary
for the binding of SLP-65 [30]) was effective in this respect
(Fig. 3B). This strongly suggests that the SHIP1 SH2-domain interacts
with the phosphorylated N-terminal tyrosine of the Ig-α ITAM (the
YEGL motif). Intriguingly, using these peptides to pull-down proteins
from lysates of unstimulated and PV-stimulated J558L∂m cells no full-
length SHIP1 was precipitated by ITAM-related peptides. Whereas the
PTK Syk and the adaptor protein Shc bound speciﬁcally to the phos-
phorylated Ig-α ITAM (P-PepI), no binding of SHIP1 to this phospho-
peptide was measured (Fig. 3C). SHIP1 also did not interact with P-
PepII. However, SHIP1 bound strongly and speciﬁcally to the FcγRIIB
P-ITIM peptide (Fig. 3C and [31]). In lysates from stimulated cells,
Shc also bound to the P-ITIM peptide, probably via its interaction
with phosphorylated SHIP1. These data demonstrate that in deter-
gent lysates, full-length SHIP1 neither directly nor indirectly binds
to the phosphorylated tail of Ig-α.
3.5. The C-terminus of SHIP1 suppresses the interaction of SHIP1 with
Ig-α
In this study so far, a murine monoclonal antibody (P1C1) has
been used for SHIP1 detection that binds to SHIP1 within its
C-terminus (aa 866–1020) (Fig. 4A). This suggests that full-lengthFig. 4. Interaction between the SH2-domain and the C-terminus of SHIP1. A. Schematic
view of SHIP1 and the epitopes of the anti-SHIP1 antibodies N1, P1C1, and M14
(depicted by brackets). The position, where SHIP1 798Stop ends, is indicated. The two
NPxY sequences within the C-terminus are marked with Ys. B. S2 cells were transfected
either with a plasmid coding for HA-SHIP1 or with plasmids coding for HA-SHIP1 and
SH2(SHIP1)-YFPv. PS were either analyzed by direct immunoblotting (left panels) or
subjected to immunopuriﬁcation using anti-GFP antibody (right panels). PS and pre-
cipitates were analyzed by anti-SHIP1 (P1C1; upper panels) and anti-GFP Western
blotting (lower panels). C. S2 cells were transfected to express either HA-SHIP1 or
SHIP1 798Stop. PS were subjected to direct Western blotting (anti-SHIP1 (N1); left
panel) or to pulldown using P-ITAM (= P-PepI; middle panel) or P-ITIM (right
panel) peptides followed by anti-SHIP1 (N1) immunoblotting. Different SHIP1 forms
are indicated by arrows.
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subject to detection by the P1C1 anti-SHIP1 antibody) is unable to
bind to the P-PepI peptide (see Fig. 3C). This may be due to the
SH2-domain being engaged intra- or inter-molecularly with the C-
terminus of the same SHIP1 molecule, since the SH2(SHIP1)-YFPv fu-
sion protein was readily bound by P-ITAM peptide. Thus, we analyzed
whether the SH2-domain of SHIP1 can interact with the complete
SHIP1 molecule. SHIP1 was expressed in Drosophila S2 cells with or
without the SH2(SHIP1)-YFPv fusion protein and an immunopuriﬁca-
tion with anti-GFP antibodies was performed. Indeed, SHIP1 could be
co-immunopuriﬁed with the SH2(SHIP1)-YFPv fusion protein
(Fig. 4B). To test our hypothesis further, we expressed full-length
SHIP1 as well as a truncated version of SHIP1 (798Stop), which still
contains the catalytic region and cannot be detected by the P1C1 an-
tibody (Fig. 4A), in S2 cells and performed peptide pull-down assays
with P-ITIM as well as P-ITAM (= P-PepI) peptides. Precipitated
SHIP1 molecules were detected by an anti-SHIP1 antibody (N1),
which binds the SH2-domain of SHIP1 (Fig. 4A). SHIP1 798Stop was
pulled down by both P-ITAM and P-ITIM peptides with P-ITIM being
more effective than P-ITAM (Fig. 4C, compare lanes 4 and 6). This sug-
gests that SHIP1 798Stop is lacking the C-terminal region responsible
for intra- or inter-molecular binding of the SH2-domain.
Transfection of S2 cells with SHIP1-encoding cDNA results in
expression of different forms of SHIP1, most probably due to post-
translational C-terminal proteolytic cleavage [16]. These are full-
length SHIP1 (p145) and truncated SHIP1 forms (p135 and
p110). Interestingly, in contrast to the longer forms of SHIP1 (p145
and p135), SHIP1 (p110) was able to interact with both P-ITAM of
Ig-α and P-ITIM of FcγRIIB (Fig. 4C, compare lanes 3 and 5). Our data
suggest that the SH2-domain of SHIP1 can bind to the SHIP1 C-
terminus and this interaction might inhibit interaction between
SHIP1 and the phosphorylated ITAM sequence of Ig-α.Fig. 5. Dimerization of SHIP1. A. Schematic view of putative SHIP1 oligomerization. B. Sche
anti-SHIP1 antibodies, N1 and M14, are indicated by brackets. C. S2 cells were transfected
SHIP1. PS were subjected to immunopuriﬁcation with anti-SHIP1 antibodies (M14) and p
right panel) Western blotting. Moreover, PS were directly analyzed for expression of SHIP13.6. SHIP1 molecules are able to dimerize
The results presented so far lead to the conclusion that the SHIP1
SH2-domain interacts intra-molecularly with the SHIP1 C-terminus
and/or interacts inter-molecularly with the C-terminus of a second
SHIP1 molecule. This would lead to dimerization or even to oligomer-
ization of SHIP1 (exemplarily shown in Fig. 5A). To test the latter hy-
pothesis, full-length SHIP1 was co-expressed with SHIP1 798Stop in S2
cells and immunopuriﬁcation was carried out with anti-SHIP1 anti-
body (M14), which is capable of binding to full-length SHIP1
(Fig. 4A), but not to the latter (Fig. 5C, lanes 1 and 2). This resulted
in the co-puriﬁcation of SHIP1 798Stop, which could be detected
with the anti-SHIP1 antibody (N1) (Fig. 5C, lanes 4 and 5). According-
ly, a smaller form of SHIP1 (marked by an asterisk) unable to bind to
the M14 antibody was co-puriﬁed (Fig. 5C, compare lanes 2 and 5).
These data indicate that SHIP1 is able to dimerize/oligomerize
(Fig. 5A). Next, we sought to determine whether the interaction of
the SH2-domain of one SHIP1 molecule with the C-terminus of a sec-
ond SHIP1 molecule is enough to facilitate the SHIP1–SHIP1 associa-
tion. To this end, SHIP1 798Stop was co-expressed with a SHIP1
molecule lacking its SH2-domain (ΔSH2-SHIP1) (Fig. 5C, lane 3) and
immunopuriﬁcation with anti-SHIP1 antibody (M14) was performed
(a model is shown in Fig. 5B). Indeed, SHIP1 798Stop was co-puriﬁed
with ΔSH2-SHIP1 as observed by anti-SHIP1 (N1) immunoblotting
(Fig. 5C, lane 6).
3.7. The SHIP1 SH2-domain interacts with phosphorylated NPxY1020
Next, we aimed at identifying the tyrosine residue in the SHIP1 C-
terminus, which upon phosphorylation enables interaction with the
SHIP1 SH2-domain. Using the SMALI web tool [36], SHIP1's Y1020
was listed as highly potential interaction site for the SH2-domain ofmatic view of the interaction between ΔSH2-SHIP1 and SHIP1 798Stop. The epitopes of
to express SHIP1 798Stop, SHIP1 798Stop and HA-SHIP1, or SHIP1 798Stop and ΔSH2-
recipitates were analyzed by anti-SHIP1 (M14; upper left panel) or anti-SHIP1 (N1;
798Stop by immunoblotting with anti-SHIP1 (N1) antibodies (lower left panel).
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binding to phosphotyrosine motifs with the SH2-domain of SHIP1
[37]. Indeed, SHIP1 could be puriﬁed from lysates of unstimulated
J558L cells using a phosphorylated peptide corresponding to the
amino acid sequence around Y1020 (Fig. 6A). In contrast, the depho-
sphorylated peptide was very inefﬁcient in purifying SHIP1
(Fig. 6A). To rule out that SHIP1 was only pulled down by the phos-
phorylated peptide via a linker protein binding to both the peptide
and SHIP1, the peptide was tested to bind to recombinant GST-
SH2(SHIP1). Again, the phosphorylated peptide pulled down GST-
SH2(SHIP1) markedly more efﬁcient than the unphosphorylated
peptide (Fig. 6B). GST alone, though used in vast excess, was only
marginally precipitated and there was no difference between phos-
phorylated and unphosphorylated peptides (Fig. 6B). Next, SHIP1 dimer-
ization/oligomerization was analyzed in J558L cells. As shown in Fig. 6C,
full-length SHIP1 was immunoprecipitated with anti-SHIP1 antibody
(M14) from J558L lysates and co-puriﬁed SHIP1 molecules of shorter
length were detected by Western blotting with anti-SHIP1 antibody
(N1). The molecular weight of this band is approximately 110 kDa,
which is consistent with the expected size of a shorter form of SHIP1
lacking a part of the C-terminus [15,16]. This indicates presence of at
least SHIP1 dimers in J558L cells. Finally, we sought to determine theFig. 6. The SHIP1 SH2-domain binds to phosphorylated Y1020 in the SHIP1 C-terminus.
A. PS of J558L cells were subjected to pull-down with NPXY or p-NPXY peptides corre-
sponding to the amino acid sequence around SHIP1's Y1020. Precipitates were analyzed
by anti-SHIP1 (N1) immunoblotting. SHIP1 is indicated by arrows. Cross-reacting
bands conﬁrming comparable loading are marked by asterisks. B. GST (lanes 1 and 2)
or GST-SH2(SHIP1) (lanes 3 and 4) were subjected to pull-down with NPXY or
p-NPXY SHIP1-peptides. Precipitates were analyzed by anti-GST Western blotting
(left panel). The right panel shows the amount of GST (lane 5) or GST-SH2(SHIP1) pro-
teins (lane 6) used in this experiment. C. J558L cells were lysed and PS were subjected
to anti-SHIP1 (M14) immunopuriﬁcation. Precipitates were analyzed by anti-SHIP1
(M14; left panel) and anti-SHIP1 (N1; right panel) immunoblotting to visualize full-
length SHIP1 and copuriﬁed smaller SHIP1 forms, respectively. Full-length SHIP1 is
marked by an arrow and a shorter form of SHIP1 with an asterisk. D. BMMCs were
lysed and PS were subjected to anti-SHIP1 (M14) immunoprecipitation. Precipitates
(IP) as well as PS were analyzed by anti-SHIP1 (M14; left panel) and anti-SHIP1 (N1;
right panel) immunoblotting. Full-length SHIP1 is marked by an arrow and a shorter
form of SHIP1, detected by N1, with an asterisk.presence of SHIP1–SHIP1 complexes in a different hemopoietic cell
type, in which SHIP1 function has been demonstrated to be of relevance
for the control of multiple effects or functions, namely bone marrow-
derived mast cells (BMMCs) [10,38]. Immunopuriﬁcation from detergent
lysates was carried out with anti-SHIP1 (M14) and Western blot analysis
was performed with M14 as well as N1 anti-SHIP1 antibodies (Fig. 6D).
Again, smaller SHIP1 isoforms (detected by N1) were co-puriﬁed with
the M14 antibody, indicating a general nature of SHIP1–SHIP1 com-
plexes in hemopoietic cells. The high molecular weight form of SHIP1,
speciﬁcally recognized and precipitated by the M14 antibody, is enriched
in the immunoprecipitates. The low molecular weight form of SHIP1 (as-
terisk), however, seems not to be enriched in a comparable manner,
suggesting that the interaction between high and low molecular weight
forms of the protein cannot be thus quantitatively correlated.
4. Discussion
The BCR regulates B cell differentiation, proliferation, and activa-
tion [18] and depending on the developmental step it can do so in
an antigen-dependent as well as -independent fashion [39]. Therein,
the Ig-α/Ig-β heterodimer plays a central role by coupling the BCR
to the intracellular signaling machinery via its cytoplasmic ITAM-
containing tails. By far, most of the interactions between BCR and in-
tracellular signaling molecules are dependent on Ig-α/Ig-β tyrosine
phosphorylation. The respective intracellular signaling proteins con-
tain one or more SH2-domains enabling them to bind to the various
phosphorylated tyrosine(s) of Ig-α/Ig-β, thus contributing to the acti-
vation of different signaling pathways.
Since there is a so-called functional dichotomy between ITAM and
ITIM sequences, it was even more intriguing when two groups
reported on a negative signaling role for Ig-α in immature B cells
[20,21]. Immature B cells from mice which carry a C-terminal trunca-
tion of Ig-α (Ig-αΔc/Δc mice) respond to BCR engagement with an ex-
aggerated and prolonged calcium response and induction of protein
tyrosine phosphorylation. In keeping with the activating nature of
the ITAM one could assume that Ig-α couples indirectly, via its interac-
tion with an activating element (e.g. Syk or Lyn), to a downstream-
located negative regulatory element, which then establishes a negative
feedback loop. Otherwise, Ig-αmight be capable of directly interacting
with one or more negative regulator(s). The PTK Lyn might be a prom-
ising candidate since it is able to initiate a well-studied negative feed-
back via the co-receptor CD22 and the PTP SHP-1 with strong impact
on BCR-mediated calcium mobilization and tyrosine phosphorylation
[40,41]. However, with respect to its binding to the BCR, Lyn seems
not to discriminate strongly between Ig-α and Ig-β [42] and thus the
pronounced effect of the truncation of the Ig-α C-terminus cannot be
explained.
We have studied the effect of a C-terminal truncation of Ig-α on
PV-induced substrate tyrosine phosphorylation and identiﬁed the
inositol 5′-phosphatase SHIP1, the tyrosine phosphorylation of
which is strongly dependent on the Ig-α tail. Using biochemical as
well as cell biological in vitro and in vivo systems, we demonstrated
direct interaction between the SH2-domain of SHIP1 and tyrosine-
phosphorylated Ig-α. The interaction between full-length SHIP1 and
Ig-α, however, does not have afﬁnity high enough for being observed
in detergent lysates. Interestingly, different ITAMs seem to possess
varying afﬁnities for SHIP1, since SHIP1 can be pulled-down from cel-
lular lysates by FcεR1 β-chain ITAM phosphopeptides, but not by
FcεR1 γ-chain ITAM phosphopeptides [12]. Furthermore, the phos-
phorylated ITAM of the FcγRIIa has been demonstrated to strongly
bind to the SH2-domain of SHIP1 in vitro [43]. Moreover, Pesesse et
al. have shown binding of SHIP1 and SHIP2 via their SH2-domains
to a tyrosine-phosphorylated peptide mimicking an immunoreceptor
signaling motif (combining activating and inhibitory properties) [44].
Since sequence differences between Ig-α and Ig-βwith respect to the
N-terminal ITAM tyrosine appear, on ﬁrst sight, non-dramatic (ENL
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very selective (it only binds to Ig-α and not to Ig-β) and thus binding
of it to a so far non-studied ITAM has to be newly analyzed by bio-
chemical means.
Several features of SHIP1 make it a likely candidate to transduce
some of Ig-α's negative signals and thus to contribute to the pheno-
type of the Ig-αΔc/Δc mice: i) SHIP1 is known in the context of several
activating receptor systems (FcεR1, BCR, c-kit) to be a negative regu-
lator of calcium mobilization [7,10,45]; ii) SHIP1 is involved in the at-
tenuation of BCR-mediated MAPK and PKB signaling [46]; and iii) the
SH2-domain of SHIP1 strongly discriminates between Ig-α and Ig-β
(this study).
Our ﬁnding that full-length SHIP1 in comparison to shorter forms
of this molecule is unable to bind to Ig-α was unexpected in the be-
ginning. A possible explanation was obtained by the ﬁnding that the
SH2-domain of SHIP1 can interact with the phosphorylated Y1020 in
SHIP1's C-terminus allowing for inter- and most probably intramolec-
ular interactions. Though intramolecular interaction was not formally
proven, its presence seems very likely based on the published crystal
structure of the 5′-phosphatase synaptojanin [47]. Like in SHIP1, the
5′-phosphatase domain of synaptojanin is centrally located in the
molecule and the N- and C-terminal extensions enter and leave, re-
spectively, the catalytic domain at the same side of its globular struc-
ture [47]. In the case of SHIP1 such a structure would strongly
promote the interaction of the SH2-domain with the C-terminus of
the same molecule. Irrespective of the question whether the SH2-
domain of SHIP1 binds inter- or intramolecularly to the SHIP1 C-
terminus, in full-length SHIP1 the SH2-domain seems to be blocked
and thus not available for binding to the Ig-α ITAM. This suggests
that primarily shorter forms of SHIP1, which are not tyrosine-
phosphorylated, bind to Ig-α. Otherwise, release of the SH2-domain
of full-length SHIP1 from the inter-/intra-molecular interaction
would allow for Ig-α binding of full-length SHIP1. Y1020 is part of an
NPxY motif known to bind, in its phosphorylated form, to PTB-
domain-containing proteins like Shc or Dok-1 [5,48]. Thus, binding
of Shc/Dok-1 to the C-terminus of SHIP1 would allow for the release
of SHIP1's SH2-domain and its interaction with another binding part-
ner, such as tyrosine-phosphorylated Ig-α.
There is still another problem to be discussed. The SH2-domain of
SHIP1, even when released from competing interactions, has to com-
pete against the tyrosine kinase Syk, which via its tandem-SH2 do-
mains can tightly bind to the phosphorylated ITAM of Ig-α [49]. In
our experiments analyzing membrane recruitment of a GST-
SH2(SHIP1) protein by the BCR, the potential of the SHIP1 SH2-
domain to compete against Syk binding is clearly shown. Interestingly,
recent data on Syk function in B cells sheds light on a possible scenario
[50]. Syk has been demonstrated to act as a dual-speciﬁcity kinase
phosphorylating Ser197 within the Ig-α cytoplasmic tail. Ser197 is lo-
cated close to the C-terminal tyrosine of the Ig-α ITAM (Tyr193) and
its phosphorylation results in release of Syk from Ig-α [50]. Since
SHIP1 via its SH2-domainmost likely binds to the N-terminal ITAM ty-
rosine, as suggested by our peptide-pulldown data, the Ig-α ITAM
phosphorylated on the ITAM tyrosines as well as Ser197 would be
well accessible for SHIP1. Thus, an exchange of an activating signaling
protein (Syk) against an inhibitory molecule (SHIP1) would be
realized.
Since SHIP1 is such a powerful negative regulator, hemopoietic
cells have to possess several means to control SHIP1's activity and/
or localization. However, the regulation of the regulator itself is only
slowly becoming evident. In this respect, our data offer a model in
which SHIP1-receptor interactions via SHIP1's SH2-domain are regu-
lated via afﬁnity differences for SHIP1's SH2-domain between the re-
spective receptor and SHIP1's C-terminus. Thus, high-afﬁnity
phosphotyrosines, like the P-ITIM of FcγRIIB, are able to release full-
length SHIP1 from their inter- or intramolecular N-terminus-to-C-ter-
minus interaction. In contrast, low-afﬁnity phosphotyrosines, like theP-ITAM of the BCR/Ig-α, are unable to do so. Therefore, these recep-
tors can only – or speciﬁcally – interact with shorter forms of SHIP1.
The different properties of full-length vs. short forms of SHIP1 are
not known yet, however, most probably differences in respective sig-
naling complexes will occur. Interestingly, Garrison and coworkers
have demonstrated recently that a SHIP1 molecule lacking its C-
terminus (truncation mutant 1–822) is activated about 8–10 fold
compared to full-length SHIP1 [51]. This suggests that SHIP1's C-
terminus not only controls interactions of SHIP1 with respective
binding partners, but also the catalytic activity of SHIP1. These two
functions are very likely coupled. In this regard, truncation of the ho-
mologous SHIP2 molecule by removal of the C-terminal region (trun-
cation mutant 1–822 as well) has also been shown to activate the
enzyme [52]. In analogy, this might suggest that the SH2-domain of
SHIP2 can bind to the single NPxY sequence within the molecule's
C-terminus as well. In this respect, interaction between SHIP2 and
SHIP1 has been demonstrated to be dependent on the SH2-domain
of SHIP2 [53]. However, no interacting phosphorylated tyrosine resi-
due in SHIP1 was identiﬁed. Moreover, SH2-domain-dependent
SHIP2–SHIP2 interaction has been shownwith the E3-ligase c-Cbl dis-
cussed as a potential bridging protein [54].
In conclusion, a major future task would be to unravel the proper
regulation of SHIP1 and SHIP2 with respect to intra-/inter-molecular
interactions and catalytic function. Given SHIP1's and SHIP2's regula-
tory roles in inﬂammation, allergy, osteoporosis, and diabetes
[55–58], this upcoming information will certainly be of pharmacolog-
ical interest.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.bbamcr.2011.11.019.Acknowledgments
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